Proj. 3 - Proteomic Response of Epithelial Cell Interactions with HIV
项目。
基本信息
- 批准号:8254424
- 负责人:
- 金额:$ 31.32万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AddressAdhesionsAfrican AmericanAnatomic SitesAnatomyAnti-Retroviral AgentsApoptosisBenchmarkingBindingBiological ProcessCXCR4 geneCell CommunicationCell DeathCell ProliferationCellsChemotaxisChronicClinicalCoculture TechniquesCommunitiesComplicationCytoplasmic TailDataDefensinsDendritic CellsEnvironmentEpidemiologyEpithelialEpithelial CellsEpitheliumEventExhibitsExposure toFemaleFutureGenital systemGrowthHIVHIV InfectionsHIV SeropositivityHIV-1HeterosexualsHighly Active Antiretroviral TherapyHumanHuman PapillomavirusImmature MonocyteImmuneImmune responseImmunocompromised HostImmunologic Deficiency SyndromesIn VitroIndividualInfectionInflammatoryInterventionLeukocyte L1 Antigen ComplexLichen PlanusLigandsLocationMessenger RNAMolecular ProfilingMucosal ImmunityMucous MembraneMutationNormal tissue morphologyNucleosidesOralOral ManifestationsOral candidiasisOral cavityOral mucous membrane structureOropharyngealPatientsPhenotypePhosphorylationPlayPopulationPredispositionProductionPropertyProtease InhibitorProtein AnalysisProteinsProteomeProteomicsPsoriasisRecruitment ActivityReverse Transcriptase InhibitorsRiskRoleRouteSLPI geneSamplingSignal TransductionSiteSkinSpottingsStromal Cell-Derived Factor 1SyndromeTestingTherapeuticTissuesTranslatingUndifferentiatedVaginaViralVulnerable PopulationsWound Healingacronymsantimicrobial peptidearrestin3basebeta-Defensinsbeta-defensin 3beta-defensin-2chemokinecohortcytokinedesensitizationinsightinterestkeratinocytemalemonocyteoral cavity epitheliumoral wartprotein expressionprotein profilingreceptor internalizationrectalresearch studyresponsesteroid hormonetransmission process
项目摘要
We have previously demonstrated that oral epithelia produces human beta defensin-2 and-3
(hBD2, 3), innate immune molecules ordinarily inducible under inflammatory conditions for most
epithelia, at higher endogenous levels in oral epithelia. Using 2D-DIGE assessment of human oral
epithelial cells from HIV+ and HIV- individuals from vulnerable populations (mainly African
Americans), we identified 153 proteins of interest; 137 (-90%) were down-regulated and 16 were
up-regulated in samples obtained from HIV positive individuals versus control. Interestingly, in
terms of their biological functions and significance, protein profiles consistent with cell death
(apoptosis) were the most numerous followed by cell proliferation proteins as well as immunological
response proteins, suggesting that both cellular and innate immune mechanisms may be altered as
a result of HIV infection. Understanding the role that the epithelium plays in HIV infection and
inherent differential susceptibility properties of epithelial tissues derived from various anatomic
locations is of interest. We propose to (I) compare proteomic profiles of human oral epithelial cells
(HOECs), female genital track epithelial cells (FGTECs) and skin-derived epithelial cells (SDECs)
from HIV+ and HIV- subjects and to examine protein profiles in these epithelia following in vitro
challenge with HIV or HAART therapy; (II) Compare innate and cellular immune response
molecules among HOECs, FGTECs and SDECs at baseline and following challenge with HIV and
HAART treatment as well as among epithelial cells obtained from wart (oral and vaginal) tissue; (III)
Determine if proteomic response from HOECs, FGTECs or SDECs are altered by co-incubation
with immune-derived undifferentiated and/or differentiated cells following exposure to human beta
defensins. We hypothesize that beta defensins, and other antimicrobial peptides are elevated in
tissue undergoing growth and high proliferation rates and that elevated levels of innate immune
molecules could result in less viral transmission through the mucosal barrier. Additionally, oral
complications of HIV infection may be altered by HIV therapeutics such as HAART or differences in
endogenous levels of antimicrobial peptides. By studying protein profiles in the genital epithelia, a
site extremely susceptible to HIV trancytosis and infection, and comparing them to oral and skin
mucosa, new insights will be gained which could then be translated in the future into promoting
protection in vulnerable mucosal barriers.
我们以前已经证明口腔上皮产生人β -防御素-2和3
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
THOMAS S MCCORMICK其他文献
THOMAS S MCCORMICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('THOMAS S MCCORMICK', 18)}}的其他基金
Differential Diagnosis of recurrent GBM versus Radiation Necrosis using MDSCbiomarkers
使用 MDSC 生物标志物鉴别诊断复发性 GBM 与放射性坏死
- 批准号:
10330027 - 财政年份:2021
- 资助金额:
$ 31.32万 - 项目类别:
Proj. 3 - Proteomic Response of Epithelial Cell Interactions with HIV
项目。
- 批准号:
8462470 - 财政年份:
- 资助金额:
$ 31.32万 - 项目类别:
Proteomic Response of Oral and Intestinal Epithelial Cells to HIV
口腔和肠道上皮细胞对 HIV 的蛋白质组反应
- 批准号:
7617381 - 财政年份:
- 资助金额:
$ 31.32万 - 项目类别:
Proj. 3 - Proteomic Response of Epithelial Cell Interactions with HIV
项目。
- 批准号:
7685067 - 财政年份:
- 资助金额:
$ 31.32万 - 项目类别:
Proteomic Response of Oral and Intestinal Epithelial Cells to HIV
口腔和肠道上皮细胞对 HIV 的蛋白质组反应
- 批准号:
8248801 - 财政年份:
- 资助金额:
$ 31.32万 - 项目类别:
Proteomic Response of Oral and Intestinal Epithelial Cells to HIV
口腔和肠道上皮细胞对 HIV 的蛋白质组反应
- 批准号:
8053328 - 财政年份:
- 资助金额:
$ 31.32万 - 项目类别:
相似海外基金
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y004841/1 - 财政年份:2024
- 资助金额:
$ 31.32万 - 项目类别:
Research Grant
Defining a role for non-canonical mTORC1 activity at focal adhesions
定义非典型 mTORC1 活性在粘着斑中的作用
- 批准号:
BB/Y001427/1 - 财政年份:2024
- 资助金额:
$ 31.32万 - 项目类别:
Research Grant
How tensins transform focal adhesions into fibrillar adhesions and phase separate to form new adhesion signalling hubs.
张力蛋白如何将粘着斑转化为纤维状粘连并相分离以形成新的粘连信号中枢。
- 批准号:
BB/Y005414/1 - 财政年份:2024
- 资助金额:
$ 31.32万 - 项目类别:
Research Grant
Development of a single-use, ready-to-use, sterile, dual chamber, dual syringe sprayable hydrogel to prevent postsurgical cardiac adhesions.
开发一次性、即用型、无菌、双室、双注射器可喷雾水凝胶,以防止术后心脏粘连。
- 批准号:
10669829 - 财政年份:2023
- 资助金额:
$ 31.32万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 31.32万 - 项目类别:
Improving Maternal Outcomes of Cesarean Delivery with the Prevention of Postoperative Adhesions
通过预防术后粘连改善剖宫产的产妇结局
- 批准号:
10821599 - 财政年份:2023
- 资助金额:
$ 31.32万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10841832 - 财政年份:2023
- 资助金额:
$ 31.32万 - 项目类别:
Prevention of Intraabdominal Adhesions via Release of Novel Anti-Inflammatory from Surface Eroding Polymer Solid Barrier
通过从表面侵蚀聚合物固体屏障中释放新型抗炎剂来预防腹内粘连
- 批准号:
10532480 - 财政年份:2022
- 资助金额:
$ 31.32万 - 项目类别:
I-Corps: A Sprayable Tissue-Binding Hydrogel to Prevent Postsurgical Cardiac Adhesions
I-Corps:一种可喷雾的组织结合水凝胶,可防止术后心脏粘连
- 批准号:
10741261 - 财政年份:2022
- 资助金额:
$ 31.32万 - 项目类别:
Sprayable Polymer Blends for Prevention of Site Specific Surgical Adhesions
用于预防特定部位手术粘连的可喷涂聚合物共混物
- 批准号:
10674894 - 财政年份:2022
- 资助金额:
$ 31.32万 - 项目类别: